Arcus Biosciences, Inc. (RCUS) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$6,929
Total Return
-30.71%
CAGR
-7.08%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +0.82% |
| Median | -0.22% |
| Best | +52.43% |
| Worst | -45.29% |
| % of Windows Positive | 49.7% |
1-Year (252 Trading Days)
| Average | -12.13% |
| Median | -21.07% |
| Best | +229.69% |
| Worst | -61.16% |
| % of Windows Positive | 20.7% |
3-Year (756 Trading Days)
| Average | -42.72% |
| Median | -51.59% |
| Best | +39.78% |
| Worst | -81.43% |
| % of Windows Positive | 11.2% |
Risk Metrics
| Maximum Drawdown | -85.83% |
| Average Drawdown | -53.81% |
| Drawdown Duration | 1098 Trading Days (Unrecovered) |
| Sortino Ratio | 0.33 |
| Calmar Ratio | -0.08 |
| CVaR (5%) | -8.70% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -3.44% (-11.57% ann.) | $344.11 | $0.00 | $0.00 | $0.00 |
| 2025 | +60.04% | +$6004.04 | $0.00 | $0.00 | $0.00 |
| 2024 | -22.04% | $2204.19 | $0.00 | $0.00 | $0.00 |
| 2023 | -7.64% | $764.03 | $0.00 | $0.00 | $0.00 |
| 2022 | -48.90% | $4890.04 | $0.00 | $0.00 | $0.00 |
| 2021 | +55.89% | +$5589.36 | $0.00 | $0.00 | $0.00 |
| 2020 | +157.03% | +$15702.96 | $0.00 | $0.00 | $0.00 |
| 2019 | -6.22% | $622.09 | $0.00 | $0.00 | $0.00 |
| 2018 partial | -36.65% (-43.61% ann.) | $3664.71 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | March 15, 2018 – February 19, 2020 | -7.41% | -3.91% | $741.18 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -34.17% | -99.15% | $3416.93 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +65.07% | +123.98% | +$6506.51 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +109.57% | +101.76% | +$10956.80 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -44.68% | -46.67% | $4468.04 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -40.10% | -24.16% | $4010.02 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +39.54% | +23.66% | +$3953.91 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.